thalassemie

Thalassemia is a group of inherited blood disorders characterized by reduced or absent synthesis of globin chains, which are essential components of hemoglobin. Hemoglobin is responsible for carrying oxygen from the lungs to the rest of the body. When globin chains are not produced in sufficient amounts, the body cannot produce enough functional hemoglobin, leading to anemia. This can manifest as fatigue, weakness, pale skin, and shortness of breath.

There are two main types of thalassemia: alpha-thalassemia and beta-thalassemia, depending on which globin chain is affected. The severity of thalassemia ranges from mild, where individuals may have no noticeable symptoms, to severe, which requires regular blood transfusions and can lead to life-threatening complications. Severe forms can also cause bone deformities, enlarged spleen and liver, and growth delays.

Thalassemia is inherited, meaning it is passed down from parents to their children. It is most common in people of Mediterranean, South Asian, Southeast Asian, and African descent. Diagnosis is typically made through blood tests that measure hemoglobin levels and red blood cell characteristics, along with genetic testing to identify specific gene mutations.

Management of thalassemia depends on its severity. Mild forms may not require treatment. More severe forms often necessitate lifelong blood transfusions to maintain adequate hemoglobin levels. Iron chelation therapy is also crucial to prevent iron overload caused by frequent transfusions. In some cases, bone marrow or stem cell transplantation can be a curative option. Genetic counseling is important for individuals and families affected by thalassemia.